Ati cautat: terapie pacienti
Protocol terapeutic: A020E – DCI PIOGLITAZONUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A018E – DCI INSULINUM ASPART (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A017E – DCI INSULINUM LISPRO (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A016E – DCI INSULINUM ASPART (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A015E – DCI INSULINUM LISPRO (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A014E – DCI AGALSIDASUM BETA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A008E – DCI IMIGLUCERASUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A005E – DCI PARICALCITOLUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
17 molecule noi au fost aprobate in tratamentul bolilor rare
Protocol terapeutic: A001E – DCI ORLISTATUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
